Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Medical Device
Singapore-based Endofotonics operates in Medical Device. It is privately held, and its site is endofotonics.com. It holds one address on record, all in Singapore. Headcount on record is 3. Its work is tagged advanced manufacturing and medical devices. One Singapore registration (UEN) is a confirmed match. Its latest round on record is Series B, US$8.5M. It is listed alongside five similar brands, mostly in Medical Device.
UEN201323074M
| ENDOFOTONICS PTE. LTD. | UEN 201323074M |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Endofotonics is a medtech organisation dedicated to using its proprietary Raman spectroscopy platform technology to improve early cancer detection and hence reduce cancer burden in patients.
To find out more, visit us at www.endofotonics.com or email your enquiries to contact@endofotonics.com
Follow and like us on facebook.com/endofotonics _
Founded in 2013, the company is headquartered in Singapore and has a subsidiary in Shanghai, China. Endofotonics developed the SPECTRA IMDx™ system, the world's first real-time in-vivo Raman spectroscopy platform, that improves early gastric cancer detection rate.
Endofotonics is currently ran by a lean team of highly skilled and specialized engineers and PhD executives, with knowledge ranging from optics to biomedical, and skills from academic research to industrial product development. Overseeing Endofotonics as a business, the company is supported by board of directors and engineering scientific board that comprises of founders and thought leaders in their own field.
Endofotonics raised S$12 million in Series B funding earlier this year. This funding will be used to support the commercialisation of the SPECTRA IMDx in Asia Pacific and beyond.
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
| Rounds | 3 |
|---|---|
| Axis | 2013 to 2026 |
| Series B · 29 Jun 2020 | US$ 8.5M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
1 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One Singapore entity on ACRA: ENDOFOTONICS PTE. LTD. (UEN 201323074M), high confidence.
3 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
One address on record, Singapore only. Primary: 67 Ayer Rajah Crescent, #03-01/02, Singapore 139950.
Three rounds. Latest 29 June 2020: Series B, US$8,500,000.
Nine tags on the brand's own list, among them advanced manufacturing and medical devices.
Five peer profiles on record: NCS Group and Singapore Airlines.